Stocks and Investing
Stocks and Investing
Fri, May 12, 2023
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
Daina Graybosch Upgraded (BOLT) to Buy and Held Target at $4 on, May 12th, 2023
Daina Graybosch of SVB Leerink, Upgraded "Bolt Biotherapeutics, Inc." (BOLT) to Buy and Held Target at $4 on, May 12th, 2023.
Daina has made no other calls on BOLT in the last 4 months.
There is 1 other peer that has a rating on BOLT. Out of the 1 peers that are also analyzing BOLT, all agrees with Daina's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $3 on, Tuesday, January 24th, 2023
Contributing Sources